Dan Ru

455 citations
8 papers · 359 indexed · 1 hit paper · h-index 5
Topics
Nanoparticle-Based Drug Delivery (4 papers)Natural Compounds in Disease Treatment (4 papers)RNA Interference and Gene Delivery (2 papers)
Partner nations
ChinaAustralia

In The Last Decade

Dan Ru

7 papers receiving 356 citations

Hit Papers

Exosome-liposome hybrid nanoparticle codelivery of TP and...2022202620232024202250100150

Peers

Dan Ru
Comparison fields: 5 of 60
  • Molecular Biology 273
  • Cancer Research 125
  • Biomedical Engineering 94
  • Biomaterials 86
  • Complementary and alternative medicine 36
Replace S. Neslihan Alpay with:
S. Neslihan Alpay United States
Xiaolin Fang China
Maryam Heidarifard Iran
Vahideh Zarrin Iran
Farzad Nasri Iran
Prameswari Kasa India
Vidhi M. Shah United States
Pouria Khani Iran
Hamidreza Saebfar Iran
Yi‐An Cheng Taiwan
Dan Ru relative to S. Neslihan Alpay United States S. Neslihan Alpay's profile →
Citations per field
00.5×3.9×
S. Neslihan Alpay · 1×
Citations per year

Countries citing papers authored by Dan Ru

Since Specialization
Citations

This map shows the geographic impact of Dan Ru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Ru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Ru more than expected).

Fields of papers citing papers by Dan Ru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Ru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Ru. The network helps show where Dan Ru may publish in the future.

Co-authorship network of co-authors of Dan Ru

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Ru. A scholar is included among the top collaborators of Dan Ru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Ru. Dan Ru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4
Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancerbreakdown →
157
5 63
6 98
7 25
8 14

About Dan Ru

Dan Ru is a scholar working on Complementary and alternative medicine, Biomaterials and Cancer Research, having authored 8 papers that have together received 359 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), Natural Compounds in Disease Treatment (4 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Cancer Research (125 citations), Biomaterials (86 citations) and Complementary and alternative medicine (36 citations). Dan Ru has collaborated with scholars based in China and Australia. Frequent co-authors include Yourong Duan, Ming Shen, Qianqian Guo, Di He, Liting Wang, Ke Gong, Fangfang Liu, Li He, Dewei Zhao and He Li. Their work appears in journals such as Scientific Reports, BioMed Research International and Theranostics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026